The goal of this randomised, controlled cross-over study is to compare two mandibular repositioning devices (MRA) already on the market in the treatment of mild-to-moderate obstructive sleep apnea.
Patiënt will test the first MRA for 3 months, after a wash out period of 2 weeks they will test the second MRA for 3 months. It will be randomised what type of MRA will be tested first and second.
Provide signed and dated informed consent
Males or females aged 18 and above
Apnea-Hypopnea Index (AHI) between 5 and 30 events per hour diagnosed by a polysomnography
Previous surgery on the upper airways
None